-
1
-
-
85052549916
-
A statement by the committee on safety of drugs
-
Committee on Safety of Drugs, Combined oral Contraceptives. A statement by the committee on safety of drugs. Br Med J 1970; 1: 231-2
-
(1970)
Br Med J
, vol.1
, pp. 231-232
-
-
-
2
-
-
84975926180
-
RCOG Statement on oral contraceptives
-
Jeffcoate TNA. RCOG Statement on oral contraceptives. Br Med J 1970; 1: 293
-
(1970)
Br Med J
, vol.1
, pp. 293
-
-
Jeffcoate, T.N.A.1
-
3
-
-
0014431870
-
Investigation of deaths from pulmonary, coronary and cerebral thrombosis and embolism in women of childbearing age
-
Inman WHW, Vessey MP. Investigation of deaths from pulmonary, coronary and cerebral thrombosis and embolism in women of childbearing age. Br Med J 1968; 2: 193-9
-
(1968)
Br Med J
, vol.2
, pp. 193-199
-
-
Inman, W.H.W.1
Vessey, M.P.2
-
4
-
-
1542391494
-
A comparison of ovarian suppression and cycle control in women receiving monophasic oral contraceptives containing either 30 μg ethinylestradiol/75 μg gestodene or 20 μg ethinylestradiol/150 μg desogestrel
-
Dublin, Ireland
-
Teichmann AT, Brill K. A comparison of ovarian suppression and cycle control in women receiving monophasic oral contraceptives containing either 30 μg ethinylestradiol/75 μg gestodene or 20 μg ethinylestradiol/150 μg desogestrel. Third Congress of European Society of Contraception, Dublin, Ireland, 1994
-
(1994)
Third Congress of European Society of Contraception
-
-
Teichmann, A.T.1
Brill, K.2
-
5
-
-
0026787069
-
A randomized double-blind placebo-controlled comparison of oral contraceptives on follicular development
-
Young RL, Snabes MC, Frank ML, Reilly M. A randomized double-blind placebo-controlled comparison of oral contraceptives on follicular development. Am J Obstet Gynecol 1992; 167: 678-82
-
(1992)
Am J Obstet Gynecol
, vol.167
, pp. 678-682
-
-
Young, R.L.1
Snabes, M.C.2
Frank, M.L.3
Reilly, M.4
-
6
-
-
0023195354
-
Ovarian follicular development during oral contraceptive cycles
-
Killick SR, Eyong E, Elstein M. Ovarian follicular development during oral contraceptive cycles. Fertil Steril 1987; 48: 409
-
(1987)
Fertil Steril
, vol.48
, pp. 409
-
-
Killick, S.R.1
Eyong, E.2
Elstein, M.3
-
7
-
-
0028091146
-
Ovulation and follicular development associated with three low-dose oral contraceptives: A randomized controlled trial
-
Grimes DA, Godwin AJ, Rubin A, et al. Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial. Obstet Gynecol 1994; 83: 29-34
-
(1994)
Obstet Gynecol
, vol.83
, pp. 29-34
-
-
Grimes, D.A.1
Godwin, A.J.2
Rubin, A.3
-
8
-
-
0029071379
-
Ovarian function during low-dose oral contraceptive use
-
Egarter CH, Putz M, Strohmer H, et al. Ovarian function during low-dose oral contraceptive use. Contraception 1995; 51: 329-33
-
(1995)
Contraception
, vol.51
, pp. 329-333
-
-
Egarter, C.H.1
Putz, M.2
Strohmer, H.3
-
9
-
-
0027246087
-
Ultrasound evaluation of ovarian activity under oral contraceptives
-
Hoogland HJ, Skouby SO. Ultrasound evaluation of ovarian activity under oral contraceptives. Contraception 1993; 47: 583-90
-
(1993)
Contraception
, vol.47
, pp. 583-590
-
-
Hoogland, H.J.1
Skouby, S.O.2
-
10
-
-
0017645079
-
Low-dose combination oral contraceptives: A controlled clinical study of three different norgestrel - Ethinyl estradiol ratios
-
Arnt IC, Ferrari A, Sartoretto JN, Woutersz TB. Low-dose combination oral contraceptives: a controlled clinical study of three different norgestrel - ethinyl estradiol ratios. Fertil Steril 1977; 28: 549-53
-
(1977)
Fertil Steril
, vol.28
, pp. 549-553
-
-
Arnt, I.C.1
Ferrari, A.2
Sartoretto, J.N.3
Woutersz, T.B.4
-
11
-
-
0001020955
-
Clinical evaluation of a low dose estrogen - Progestagen combination 100 μg D-norgestrel + 20 μg ethinylestradiol
-
Sartoretto JN, Ortega Recio JC. Clinical evaluation of a low dose estrogen - progestagen combination 100 μg D-norgestrel + 20 μg ethinylestradiol. Rev Bras Clin Ther 1974; 3: 399-404
-
(1974)
Rev Bras Clin Ther
, vol.3
, pp. 399-404
-
-
Sartoretto, J.N.1
Ortega Recio, J.C.2
-
12
-
-
0013692488
-
Pharmacological features of gestodene in laboratory animals and man
-
Breckwoldt M, Düsterberg B, eds. Carnforth, UK: Parthenon Publishing
-
D̈sterberg G, Beier S, Schneider WHG, Spona J. Pharmacological features of gestodene in laboratory animals and man. In Breckwoldt M, Düsterberg B, eds. Gestodene: New Direction in Oral Contraception. Carnforth, UK: Parthenon Publishing, 1988; 13-29
-
(1988)
Gestodene: New Direction in Oral Contraception
, pp. 13-29
-
-
D̈sterberg, G.1
Beier, S.2
Schneider, W.H.G.3
Spona, J.4
-
13
-
-
0028574279
-
Progestin-only oral contraception: A comprehensive review
-
McCann MF, Potter LS. Progestin-only oral contraception: a comprehensive review. Contraception 1994; 50 (Suppl. 1): 12
-
(1994)
Contraception
, vol.50
, Issue.1 SUPPL.
, pp. 12
-
-
McCann, M.F.1
Potter, L.S.2
-
14
-
-
0029559597
-
The influence of the dose ot ethinylestradiol in oral contraceptives on follicle growth
-
Teichmann AT, Brill K, Albring M, et al. The influence of the dose ot ethinylestradiol in oral contraceptives on follicle growth. Gynecol Endocrinol 1995; 9: 299-305
-
(1995)
Gynecol Endocrinol
, vol.9
, pp. 299-305
-
-
Teichmann, A.T.1
Brill, K.2
Albring, M.3
-
15
-
-
0025799993
-
Depot-MPA and risk of epithelial cancer
-
WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Depot-MPA and risk of epithelial cancer. Int J Cancer 1991; 49: 191-5
-
(1991)
Int J Cancer
, vol.49
, pp. 191-195
-
-
|